Literature DB >> 20048199

Blood pressure, blood flow, and oxygenation in the clipped kidney of chronic 2-kidney, 1-clip rats: effects of tempol and Angiotensin blockade.

Fredrik Palm1, Maristela Onozato, William J Welch, Christopher S Wilcox.   

Abstract

Angiotensin II maintains renal cortical blood flow and renal oxygenation in the clipped kidney of early 2-kidney, 1-clip Goldblatt hypertensive (2K,1C) rats. The involvement of Ang II is believed to decline, whereas oxidative stress increases during the progression of 2K,1C hypertension. We investigated the hypothesis that the acute administration of drugs to inhibit reactive oxygen species (Tempol), angiotensin II type 1 receptors (candesartan), or angiotensin-converting enzyme (enalaprilat) lowers mean arterial pressure and increases kidney blood flow and oxygenation in the clipped kidney of chronic 2K,1C rats in contrast to sham controls. Twelve months after left renal artery clipping or sham, mean arterial pressure, renal cortical blood flow, and renal cortical and medullary oxygen tension were measured after acute administration of Tempol followed by enalaprilat or candesartan followed by enalaprilat. The mean arterial pressure of the 2K,1C rat was reduced by candesartan (-9%) and, more effectively, by Tempol (-35%). All of the applied treatments had similar blood pressure-lowering effects in sham rats (average: -21%). Only Tempol increased cortical blood flow (+35%) and cortical and medullary oxygen tensions (+17% and +94%, respectively) in clipped kidneys of 2K,1C rats. Administration of enalaprilat had no additional effect, except for a modest reduction in cortical blood flow in the clipped kidney of 2K,1C rats when coadministered with candesartan (-10%). In conclusion, acute administration of Tempol is more effective than candesartan in reducing the mean arterial blood pressure and improving renal blood perfusion and oxygenation in the clipped kidney of chronic 2K,1C rats.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20048199      PMCID: PMC2826172          DOI: 10.1161/HYPERTENSIONAHA.109.135426

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  39 in total

1.  Intrarenal oxygen tension measured by a modified clark electrode at normal and low blood pressure and after injection of x-ray contrast media.

Authors:  P Liss; A Nygren; N P Revsbech; H R Ulfendahl
Journal:  Pflugers Arch       Date:  1997-11       Impact factor: 3.657

2.  The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group.

Authors:  B C van Jaarsveld; P Krijnen; H Pieterman; F H Derkx; J Deinum; C T Postma; A Dees; A J Woittiez; A K Bartelink; A J Man in 't Veld; M A Schalekamp
Journal:  N Engl J Med       Date:  2000-04-06       Impact factor: 91.245

3.  AT1 and TxA2/PGH2 receptors maintain hypertension throughout 2K,1C Goldblatt hypertension in the rat.

Authors:  C S Wilcox; J Cardozo; W J Welch
Journal:  Am J Physiol       Date:  1996-10

Review 4.  Angiotensin-converting enzyme inhibition in renal disease; contrasting effects on renal function in renal artery stenosis and progressive renal injury.

Authors:  B Jackson; C I Johnston
Journal:  J Hum Hypertens       Date:  1989-06       Impact factor: 3.012

5.  Upregulation of autocrine-paracrine renin-angiotensin systems in chronic renovascular hypertension.

Authors:  Javid Sadjadi; Krishna Puttaparthi; M Burress Welborn; Thomas E Rogers; Orson Moe; G Patrick Clagett; Richard H Turnage; Moshe Levi; J Gregory Modrall
Journal:  J Vasc Surg       Date:  2002-08       Impact factor: 4.268

Review 6.  Hypoxia and hypoxia-inducible factor in renal disease.

Authors:  Masaomi Nangaku; Reiko Inagi; Toshio Miyata; Toshiro Fujita
Journal:  Nephron Exp Nephrol       Date:  2008-07-30

7.  Flow- and acetylcholine-induced dilatation in small arteries from rats with renovascular hypertension--effect of tempol treatment.

Authors:  Frank Holden Christensen; Edgaras Stankevicius; Thomas Hansen; Malene Munk Jørgensen; Vanesa Lopez Valverde; Ulf Simonsen; Niels Henrik Buus
Journal:  Eur J Pharmacol       Date:  2007-04-18       Impact factor: 4.432

8.  Induction of renoprotective gene expression by cobalt ameliorates ischemic injury of the kidney in rats.

Authors:  Makiko Matsumoto; Yuichi Makino; Tetsuhiro Tanaka; Hirotoshi Tanaka; Nobuhiro Ishizaka; Eisei Noiri; Toshiro Fujita; Masaomi Nangaku
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

9.  Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension.

Authors:  Bernd Klanke; Nada Cordasic; Andrea Hartner; Roland E Schmieder; Roland Veelken; Karl F Hilgers
Journal:  Nephrol Dial Transplant       Date:  2008-05-30       Impact factor: 5.992

10.  Antioxidant intervention prevents renal neovascularization in hypercholesterolemic pigs.

Authors:  Alejandro R Chade; Michael D Bentley; Xiangyang Zhu; Martin Rodriguez-Porcel; Sara Niemeyer; Beatriz Amores-Arriaga; Claudio Napoli; Erik L Ritman; Amir Lerman; Lilach O Lerman
Journal:  J Am Soc Nephrol       Date:  2004-07       Impact factor: 10.121

View more
  26 in total

Review 1.  Renal oxidative stress, oxygenation, and hypertension.

Authors:  Fredrik Palm; Lina Nordquist
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-10       Impact factor: 3.619

Review 2.  Atherosclerotic renal artery stenosis: current status.

Authors:  Soon Hyo Kwon; Lilach O Lerman
Journal:  Adv Chronic Kidney Dis       Date:  2015-05       Impact factor: 3.620

3.  Vascular Endothelial Growth Factor Therapy for the Kidney: Are We There Yet?

Authors:  Alejandro R Chade
Journal:  J Am Soc Nephrol       Date:  2015-06-02       Impact factor: 10.121

4.  Kidney hypoxia, attributable to increased oxygen consumption, induces nephropathy independently of hyperglycemia and oxidative stress.

Authors:  Malou Friederich-Persson; Erik Thörn; Peter Hansell; Masaomi Nangaku; Max Levin; Fredrik Palm
Journal:  Hypertension       Date:  2013-09-09       Impact factor: 10.190

5.  Imaging: BOLD assessment--effects of RAAS inhibition in CKD.

Authors:  Lilach O Lerman
Journal:  Nat Rev Nephrol       Date:  2014-03-25       Impact factor: 28.314

6.  Syncytial communication in descending vasa recta includes myoendothelial coupling.

Authors:  Zhong Zhang; Kristie Payne; Thomas L Pallone
Journal:  Am J Physiol Renal Physiol       Date:  2014-04-30

7.  Neuronal uptake of nanoformulated superoxide dismutase and attenuation of angiotensin II-dependent hypertension after central administration.

Authors:  Krupa Savalia; Devika S Manickam; Erin G Rosenbaugh; Jun Tian; Iman M Ahmad; Alexander V Kabanov; Matthew C Zimmerman
Journal:  Free Radic Biol Med       Date:  2014-06-09       Impact factor: 7.376

8.  High Salt Enhances Reactive Oxygen Species and Angiotensin II Contractions of Glomerular Afferent Arterioles From Mice With Reduced Renal Mass.

Authors:  Lingli Li; En Yin Lai; Zaiming Luo; Glenn Solis; Margarida Mendonca; Kathy K Griendling; Anton Wellstein; William J Welch; Christopher S Wilcox
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

Review 9.  Emerging Paradigms in Chronic Kidney Ischemia.

Authors:  Alfonso Eirin; Stephen C Textor; Lilach O Lerman
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

Review 10.  Oxidative stress in hypertension: role of the kidney.

Authors:  Magali Araujo; Christopher S Wilcox
Journal:  Antioxid Redox Signal       Date:  2013-04-30       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.